Prostate cancer: celecoxib trampled in the STAMPEDE trial

Nat Rev Urol. 2012 May 29;9(7):358-60. doi: 10.1038/nrurol.2012.112.
No abstract available

Publication types

  • News

MeSH terms

  • Androgen Antagonists / therapeutic use
  • Celecoxib
  • Humans
  • Male
  • Multicenter Studies as Topic* / trends
  • Prostatic Neoplasms / drug therapy*
  • Prostatic Neoplasms / epidemiology
  • Pyrazoles / therapeutic use*
  • Sulfonamides / therapeutic use*

Substances

  • Androgen Antagonists
  • Pyrazoles
  • Sulfonamides
  • Celecoxib